Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

This Drug Enters Cancer Cells 12.5x Faster With NO Side Effects

Researchers at Northwestern University have completely reimagined a classic chemotherapy drug using nanotechnology, transforming a weak, poorly soluble compound into a precision cancer therapy that is up to 20,000 times more effective at destroying cancer cells. The scientists created the drug entirely from scratch as a spherical nucleic acid, a nanoscale structure that incorporates the medication into DNA strands surrounding tiny spheres, which dramatically improves how the body absorbs and uses it. Traditional chemotherapy drug 5 fluorouracil dissolves so poorly that less than one percent of it works in many biological fluids, causing it to clump in solid form that the body cannot absorb efficiently while also attacking healthy tissue and causing terrible side effects like nausea, fatigue, and even heart failure. When tested in a small animal model of acute myeloid leukemia, an aggressive and hard to treat blood cancer, the redesigned version entered leukemia cells 12.5 times more efficiently, destroyed them up to 20,000 times more effectively, and slowed cancer progression by a factor of 59.

The breakthrough happened because the structural redesign changed how the drug interacted with cancer cells, allowing myeloid cells to easily recognize and absorb the spherical nucleic acid form before enzymes broke down the DNA shell to release drug molecules that killed the cancer from within. In mouse experiments, the therapy eliminated leukemia cells to near completion in the blood and spleen, significantly extended survival, and left healthy tissues completely unharmed because it selectively targeted only the cancer cells. Today’s chemotherapeutics kill everything they encounter including healthy cells, but this structural nanomedicine preferentially seeks out myeloid cells and delivers a higher, more focused dose exactly where it’s needed instead of overwhelming the whole body. With seven spherical nucleic acid based therapies already in clinical trials, this approach could pave the way for advanced vaccines and new treatments for cancer, infectious diseases, neurodegenerative disorders, and autoimmune conditions.

PrevPreviousDiagnosed At 11 And He’s CHANGING Cancer Research
NextActor Calls Kidney Donation To Stranger A NO BRAINERNext

Recent Articles

Happy News

This Stray Cat Walked Into Third Grade And Never Left

December 20, 2025

A lovable orange stray cat named Tombi appeared on the grounds of a public elementary school in Izmir, Turkey, and after spending a few weeks in the school garden seeking attention from children, he boldly ventured straight into teacher Ivaşcu’s third grade classroom where students immediately adored him. Unlike most

Read More
Happy News

This Could Become The Newest National Park

December 20, 2025

Ocmulgee Mounds, a site in central Georgia with 12,000 years of Indigenous history, may soon become the newest U.S. national park under a pending bill in Congress, though the redesignation may not include much change for the site itself beyond marketing and public perception. The 3,000 acre park protects land

Read More
Happy News

A School Bus Driver’s Special Gift To Her Riders

December 20, 2025

Tina Hutcherson, a 63 year old school bus driver for Putnam City School District in Oklahoma, has been knitting and crocheting since she was about 12 years old, and when her daughter gifted her a new knitting machine for her birthday, she realized she could finally keep all 100 of

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2025 HappyNews.